Oxaliplatin-induced Peripheral Neuropathy Clinical Trial
Official title:
Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy: A Phase II Randomized Study by UNICANCER With the Cooperation of AFSOS
It is a phase II trial, randomized, parallel, double blind, multicenter, comparing riluzole versus placebo. The trial population is composed of patients ≥18 years old that have developed stage II/III colorectal cancer and are eligible for Simplified FOLFOX4 (6-12 cycles) adjuvant chemotherapy. The primary objective is to assess the preventive efficacy of riluzole on the severity of oxaliplatin-induced peripheral neuropathy during the Simplified FOLFOX4 adjuvant chemotherapy of stage II/III colorectal cancers.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04751513 -
Auricular Acupressure : Improves Oxaliplatin-induced Peripheral Neuropathy
|
N/A |